Documents
Application Sponsors
Marketing Status
Application Products
001 | SOLUTION/DROPS;OPHTHALMIC | 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 1 | IQUIX | LEVOFLOXACIN |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2004-03-01 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2014-12-03 | STANDARD |
Submissions Property Types
CDER Filings
SANTEN
cder:Array
(
[0] => Array
(
[ApplNo] => 21571
[companyName] => SANTEN
[docInserts] => ["",""]
[products] => [{"drugName":"IQUIX","activeIngredients":"LEVOFLOXACIN","strength":"1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"12\/03\/2014","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021571s006lbl.pdf\"}]","notes":""},{"actionDate":"03\/01\/2004","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21571_iquix_lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"IQUIX","submission":"LEVOFLOXACIN","actionType":"1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2014-12-03
)
)